Target intelligence / Profile preview

Galectin-14 (LGALS14)

Target
LGALS14
Molecular classification
Lectin, Carbohydrate-binding protein, Prototype galectin family
01

Overview

Galectin-14 (LGALS14) is a carbohydrate-binding protein classified within the prototype galectin family, characterized by a single carbohydrate recognition domain (CRD) per monomer and typically forming dimers[1][2][5]. It is predominantly expressed in the human placenta, where its levels surpass other galectins, indicating a specialized role in fetal development and regulation of maternal immune tolerance during pregnancy[1][2][3]. Galectin-14 can induce T-cell apoptosis and participate in protein-protein interactions, including colocalization with c-Rel, a member of the NF-κB family, suggesting potential influence on signal transduction pathways[1][2][3]. Structurally, it is distinct from other galectins, with low affinity for lactose due to noncanonical amino acid substitutions in its binding site[1][2]. Its main biological functions and disease associations center on reproductive and immunological processes, but there are no known approved drugs or specific drug interactions targeting this protein[3].

Other names
Placental protein 13-likePPL13CLC2Gal-14Charcot-Leyden crystal protein 2lectin, galactoside-binding, soluble, 14
02

Biological functions

Carbohydrate bindingRegulation of immune tolerance during pregnancyInduction of T-cell apoptosisPossible regulation of signal transduction via NF-κB
03

Disease associations

Fetal development disordersPregnancy-related conditionsPotential immune-related conditions (research ongoing)
04

Biomarkers

Placental/fetal health marker (research and clinical studies often explore placental proteins as biomarkers)

Beyond the preview

Go deeper on Galectin-14 (LGALS14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Galectin-14 (LGALS14).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call